These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 23137018)
21. Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma. Brundler MA; Harrison JA; de Saussure B; de Perrot M; Pepper MS J Clin Pathol; 2006 Feb; 59(2):191-5. PubMed ID: 16443737 [TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrases II, IX, and XII in Barrett's esophagus and adenocarcinoma. Nortunen M; Huhta H; Helminen O; Parkkila S; Kauppila JH; Karttunen TJ; Saarnio J Virchows Arch; 2018 Nov; 473(5):567-575. PubMed ID: 30066203 [TBL] [Abstract][Full Text] [Related]
23. Diagnosis and recognition of early esophageal neoplasia. Herszényi L; Pregun I; Tulassay Z Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957 [TBL] [Abstract][Full Text] [Related]
25. Expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in astrocytic tumors. Kim NK; Ahn JY; Song J; Kim JK; Han JH; An HJ; Chung HM; Joo JY; Choi JU; Lee KS; Roy R; Oh D Anticancer Res; 2003; 23(2B):1417-23. PubMed ID: 12820404 [TBL] [Abstract][Full Text] [Related]
26. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829 [TBL] [Abstract][Full Text] [Related]
27. p53 protein accumulation predicts malignant progression in Barrett's metaplasia: a prospective study of 275 patients. Younes M; Brown K; Lauwers GY; Ergun G; Meriano F; Schmulen AC; Barroso A; Ertan A Histopathology; 2017 Jul; 71(1):27-33. PubMed ID: 28226185 [TBL] [Abstract][Full Text] [Related]
29. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia. Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445 [TBL] [Abstract][Full Text] [Related]
30. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma. Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239 [TBL] [Abstract][Full Text] [Related]
32. The use of dynamic positron emission tomography imaging for evaluating the carcinogenic progression of intestinal metaplasia to esophageal adenocarcinoma. Li Y; Woodall C; Wo JM; Zheng H; Ng CK; Ray MB; Martin RC Cancer Invest; 2008; 26(3):278-85. PubMed ID: 18317969 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Montgomery E; Mamelak AJ; Gibson M; Maitra A; Sheikh S; Amr SS; Yang S; Brock M; Forastiere A; Zhang S; Murphy KM; Berg KD Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):24-30. PubMed ID: 16540726 [TBL] [Abstract][Full Text] [Related]
34. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
35. Aurora kinase A in Barrett's carcinogenesis. Rugge M; Fassan M; Zaninotto G; Pizzi M; Giacomelli L; Battaglia G; Rizzetto C; Parente P; Ancona E Hum Pathol; 2010 Oct; 41(10):1380-6. PubMed ID: 20656315 [TBL] [Abstract][Full Text] [Related]
37. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma. Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440 [TBL] [Abstract][Full Text] [Related]
38. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844 [TBL] [Abstract][Full Text] [Related]
39. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus. Soslow RA; Remotti H; Baergen RN; Altorki NK Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608 [TBL] [Abstract][Full Text] [Related]
40. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]